Yang Ma

China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners.

Recent advances in the development of GRK2 inhibitors: blocking the interaction of GRK2 with its partners.

Journal: Acta pharmacologica Sinica

Published: December 30, 2025

Circadian clock genes: Potential therapeutic targets for autoimmune diseases.

Circadian clock genes: Potential therapeutic targets for autoimmune diseases.

Journal: Journal of autoimmunity

Published: August 30, 2025

Myeloid-derived MANF ameliorates ethanol-induced liver injury by enhancing microRNA-223 expression.

Myeloid-derived MANF ameliorates ethanol-induced liver injury by enhancing microRNA-223 expression.

Journal: Journal of gastroenterology

Published: November 21, 2024

Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis.

Paeoniflorin-6'-O-benzene sulfonate inhibits keratinocyte proliferation by restoring GRK2-JAK1 colocalization in mouse model of psoriasis.

Journal: Cellular signalling

Published: November 20, 2024

GRK2 activates TRAF2-NF-κB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

GRK2 activates TRAF2-NF-κB signalling to promote hyperproliferation of fibroblast-like synoviocytes in rheumatoid arthritis.

Journal: Acta pharmaceutica Sinica. B

Published: September 23, 2024

Inhibition of GRK2-PDE4D Axis Suppresses Fibroblast-Like Synoviocytes Hyperplasia and Alleviates Experimental Arthritis.

Inhibition of GRK2-PDE4D Axis Suppresses Fibroblast-Like Synoviocytes Hyperplasia and Alleviates Experimental Arthritis.

Journal: International journal of biological sciences

Published: June 27, 2024

G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sjögren's syndrome.

G protein-coupled receptor kinase 2 as a novel therapeutic target for gland fibrosis of Sjögren's syndrome.

Journal: Acta pharmacologica Sinica

Published: January 26, 2024

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders.

The research progression of direct NLRP3 inhibitors to treat inflammatory disorders.

Journal: Cellular immunology

Published: November 04, 2023

Involvement of Embryo-Derived and Monocyte-Derived Intestinal Macrophages in the Pathogenesis of Inflammatory Bowel Disease and Their Prospects as Therapeutic Targets.

Involvement of Embryo-Derived and Monocyte-Derived Intestinal Macrophages in the Pathogenesis of Inflammatory Bowel Disease and Their Prospects as Therapeutic Targets.

Journal: International journal of molecular sciences

Published: October 31, 2023

IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway.

IGFBP2 drives epithelial-mesenchymal transition in hepatocellular carcinoma via activating the Wnt/β-catenin pathway.

Journal: Infectious agents and cancer

Published: August 06, 2023

NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease.

NLRP3 inflammasome activation mechanism and its role in autoimmune liver disease.

Journal: Acta biochimica et biophysica Sinica

Published: September 23, 2022

A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation.

A novel GRK2 inhibitor alleviates experimental arthritis through restraining Th17 cell differentiation.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: August 26, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026